Evidence map›Paper›PMID 40721753›Full record

ReviewBMC ophthalmology2025

Endophthalmitis following inadvertent intravitreal injection of botulinum toxin: a case report and literature review.

Saud Mohammed Aljohani, Amal Salem Alharbi, Raid Mohammed Alhayaza

Abstract readCase ReportsReview
In one paragraph

Review in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Saud Mohammed AljohaniDepartment of Ophthalmology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia. dr.aljohani@live.com.ORCID http://orcid.org/0000-0001-7692-2982
Amal Salem AlharbiDepartment of Ophthalmology, Dammam Medical Complex, Dammam, Eastern Province, Saudi Arabia.ORCID http://orcid.org/0009-0009-5405-2432
Raid Mohammed AlhayazaDepartment of Ophthalmology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.ORCID http://orcid.org/0000-0002-8335-3471

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBotulinum toxin A (BTA) injection is a well-established, minimally invasive treatment for strabismus, offering an alternative to traditional surgery. While generally safe, rare complications like globe penetration and inadvertent intraocular injection have been reported. These can lead to retinal detachment, vitreous hemorrhage, and retinal toxicity. Although most intraocular BTA injection complications are well-documented, endophthalmitis remains extremely rare, with only one previously reported case resulting in total vision loss. CASE PRESENTATION: A 3-year-old boy with esotropia received a botulinum toxin A injection into the left medial rectus muscle. A globe penetration from the needle was suspected. The dilated fundus exam was unremarkable. However, one week later, he presented with eye pain, redness, and photophobia. Clinical examination confirmed the diagnosis of acute post-operative endophthalmitis. The patient underwent urgent vitreous tap, pars plana vitrectomy, Endolaser, intravitreal antibiotic injection, and silicone oil injection. Subsequently, the silicone oil with epiretinal membrane removal was performed, and the patient's vision was maintained postoperatively, CUSNM in both eyes.

conclusionThis case emphasizes the rare yet serious complications of Inadvertent Intravitreal Injection of Botulinum Toxin. It underscores the importance of early detection of endophthalmitis and timely intervention for an optimal outcome and to prevent irreversible ocular damage.

Indexed as

Botulinum Toxins, Type AEndophthalmitisEye Infections, BacterialNeuromuscular AgentsChild, PreschoolEsotropiaHumansIntravitreal InjectionsMaleOculomotor MusclesBotulinum Toxins, Type ANeuromuscular AgentsBotulinum toxinEndophthalmitisPars plana vitrectomy

Identifiers

PMID40721753
PMCPMC12302461

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.